6 September 2018

Smith & Nephew extends capacity of US professional education with opening of state-of-the-art training facility in Phoenix, Arizona

Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the opening of its new surgical training center in Phoenix, Arizona. This facility will bring professional development and skills training to customers, primarily in the West and Southwest of the United States, complementing Smith & Nephew’s existing facilities in Memphis TN, Andover MA, Austin TX and Plymouth MN.

Equipped with the latest technology and products, the world-class facility simulates a surgical environment with six hospital operating stations as well as an auditorium for lectures and high-definition video for procedure observation. Healthcare professionals will be able to learn new techniques and refine skills first hand whilst ensuring the safe and effective use of Smith & Nephew products including the new NAVIO™ robotics-assisted Surgical System.

“The opening of this new facility shows our continued commitment to high quality medical education. We’re looking forward to providing easier access to training for surgeons and nurses in the Western United States and welcoming healthcare professionals from across North America and the world as we support them in their vital work improving patient’s lives,” commented Angela Saulino, Vice President Professional Education, Smith & Nephew.

"It’s great to see Smith & Nephew’s ongoing commitment to medical education with the opening of this new training facility in Phoenix, Arizona. Smith & Nephew is improving patient outcomes with their advanced technologies, and we will now have another first-class location in which we can demonstrate these benefits to surgeons, hospital staff, residents and fellows," said Dr. Jimmy Chow M.D., Regional Medical Director, Orthopaedics Abrazo Medical Group / Tenet Healthcare.

Smith & Nephew’s hands-on training facilities are complemented by a variety of educational offerings, including interactive faculty-led courses, digital training through web-based symposia, virtual reality and its award-winning Education & Evidence online platform. Smith & Nephew provides an extensive program of global courses, with more than 45,000 instances of surgeon training worldwide on Orthopaedic Reconstruction, Trauma and Sports Medicine. For more information head to http://www.smith-nephew.com/education.



Charles Reynolds
+44 (0)1923 477314
Smith & Nephew

Dave Snyder
+1 (978) 749-1440
Smith & Nephew

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to supporting healthcare professionals in their daily efforts to improve the lives of their patients. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has more than 15,000 employees and a presence in more than 100 countries. Annual sales in 2017 were almost $4.8 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).

For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com

Forward-looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

◊ Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.